• 52,824+ CME Conference Registrations Sold
  • 158,473+ Medical Conferences
  • 285 Specialties
  • 11,438 Organizers
  • 157,242 Speakers
  • 159 Countries
  • 4,806 Cities
Home  >  Board Review Courses  >  Infectious Diseases in Adults 2020
CME : 41.25 | MOC : 41.25 | Credits : 41.25
Conference Brochure

This conference has been CANCELLED.

Infectious Diseases in Adults 2020 is organized by Harvard Medical School (HMS), The Penzias Group and will be held from Apr 28 - May 02, 2020 at Fairmont Copley Plaza, Boston, Massachusetts, United States of America.

Who Should Attend:
• Physicians, NPs, PAs in the Fields of:
• Infectious Diseases
• Hospital Medicine
• Internal Medicine
• Family Practice
• Pulmonary and Critical Care Medicine
• Emergency Medicine

Accreditation:
• 41.25 AMA PRA Category 1 CreditsTM
• 41.25 ABIM MOC points
• 41.00 AAFP Prescribed credits
• 7.25 credits of Risk Management Study, including 0.75 credits of Opioid Education and Pain Management Training

Course Description:
Infectious Diseases in Adults provides important updates and state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging. This highly rated course focuses on major clinical syndromes as well as management controversies. It features a range of case-based, interactive, and problem-solving sessions from master clinicians in the field. Topics with major impact on clinical practice are emphasized; this includes infections of national and international importance.

The course provides education that ensures attendees are current with recent developments in the prevention and management of infections, including the newer antibacterial, antiviral, and antiparasitic agents. Preventive treatments including vaccines and prophylaxis in travelers are reviewed. Newer diagnostic tests are presented. Principles of antimicrobial stewardship and infection control are highlighted.

State-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases
This comprehensive Harvard Medical School CME program-one of the highest-rated HMS CME courses-- ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven:

• Strategies for optimal decision-making in the prevention, diagnosis and treatment of infectious diseases
• Newer antimicrobials and treatment strategies for highly resistant bacterial infections
• Prevention and treatment of infection in immunocompromised hosts
• State-of-the-art approaches to common infections
• Clinical approaches to complex, rare, "don't-miss" infections
• New, evolving, and emerging infectious diseases
• Update on antifungal diagnostics and therapy
• Optimal management of Staph aureus infections
• Infections in persons with substance use disorders
• What’s new in HIV management and prevention
• Musculoskeletal infectious diseases 
• ID for hospital medicine specialists
• Workshop on resistant and difficult-to-treat infections
• Workshop on antimicrobial stewardship

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Please visit the course website at https://id.hmscme.com for a complete schedule and a comprehensive list of course highlights.

Highlights of the 2020 Program:
Expanded Case-Based and Problem-Solving Education 

The 2020 program features an expanded range of interactive, case-based and problem-solving education. The formats are engaging and attendees are encouraged to pose questions in larger sessions as well as one-on-one with the national experts who will be providing updates at this event.

Treating Highly Resistant Infections, including:
• MRSA, vancomycin-intermediate Staph aureus (VISA), and borderline oxacillin-resistant Staph aureus (BORSA)
• Extended spectrum beta-lactamase (ESBL)-producing gram negative rods
• Carbapenemase-producing gram negative rods, including the NDM-1 metallo-beta-lactamase-producing organisms
• Vancomycin-resistant enterococci (VRE) 
• Resistant and difficult-to-treat fungal infections

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment
Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:
• Infections in the growing populations of immunocompromised hosts
• Infections in pregnancy, including Zika
• Infections in persons with substance use disorders
• Infections of travelers and foreign-born persons
• Systemic fungal infections
• Native and device-related orthopedic infections
• Central nervous system (CNS) infections
• Ear, nose and throat (ENT) and eye infections
• Bronchiectasis and pneumonia
• HIV and its infectious and noninfectious complications
• PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
• Sexually transmitted infections
• Hepatitis C monoinfection and coinfection
• Tick- and mosquito-borne infections and zoonoses
• Vaccines and vaccine-preventable infections
• Clostridium difficile infection

Challenging, Rare, and Emerging Infectious Diseases
Comprehensive updates on:
• EEE, Zika, Ebola, Middle Eastern Respiratory Syndrome (MERS), and other emerging infectious diseases
• Re-emergence of vaccine-preventable diseases 
• Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
• Candida auris infection
• Global infectious diseases of clinical importance
• Zoonoses-the old and the new

Clinical Decision-Making
Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:
• Selecting the best antimicrobial and duration of treatment
• Rapid detection and empiric treatment of the life-threatening infectious diseases
• Inpatient or outpatient treatment, and the outpatient antibiotic transition: IV or oral? 
• Optimizing empiric antimicrobial therapy: what to start, when to narrow or stop

Our talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:
• Antimicrobial stewardship workshop (optional) to prevent resistance and reduce cost
• Infection control, including biothreats
• Early inpatient ID consultations to reduce mortality, length of stay, and cost
• Outpatient Parenteral Antibiotic Therapy (OPAT): best practices in program design and operation
• Strategies for management of infection in persons with substance use disorder
• Curbside consultation and e-consultation

Learning Objectives:
Upon completion of this course, participants will be able to:
• Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes
in immunocompetent and immunocompromised patients
• Summarize principles of judicious antimicrobial selection, dose, and duration to optimize patient outcomes, prevent resistance, and decrease cost
• Describe evidence-based treatments as well as new treatment paradigms for resistant or difficultto-treat infectious diseases
• Recognize the role of novel, rapid diagnostics in infectious disease practice
• Analyze key areas of recent clinical and basic science relevant to clinical care

 

View All Speaking

Elizabeth Louise Hohmann
Elizabeth Louise Hohmann

Infectious Disease

Sigal Yawetz
Sigal Yawetz

Infectious Disease

Jennifer Ann Johnson
Jennifer Ann Johnson

Infectious Disease

Tracking

Matthew Parisi
Matthew Parisi

Infectious Disease

Grant Gillis
Grant Gillis

Family Medicine

Conference Details

Session Brochure : Download Session Brochure
Session url : Click here
Workshop Details : View Workshop Details

Registration Desk

Contact No. : 617-384-8600
Email:
CEPrograms@hms.harvard.edu

View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Fairmont Copley Plaza
138 St James Ave
Boston, Massachusetts, United States of America

Official Hotel

Fairmont Copley Plaza,

138 St James Ave,

Boston, Massachusetts, United States of America 02116,

+1 617-267-5300

Plan Your Travel

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Freepoint Hotel Cambridge, Tapestry Collection by Hilton
4.35 miles from venue
, Free Wifi
Price : USD 259.00 Per Night
Hilton Boston Logan Airport
2.99 miles from venue
Price : USD 207.00 Per Night
Hotel Veritas
2.44 miles from venue
, Free Wifi
Price : USD 179.10 Per Night
Sonder — JFK Historic Site
2.07 miles from venue
, Free Wifi
Price : USD 155.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee
Advanced Cases in Resistant and Difficult-to-Treat Infections 27 Apr 2020 01:00 PM 27 Apr 2020 03:15 PM USD 200.00
Antimicrobial Stewardship Programs (ASP): Updated Principles and Practice with Instructive Case 27 Apr 2020 03:30 PM 27 Apr 2020 05:30 PM USD 200.00

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news